Skip to main content

Peer Review reports

From: Pan-cancer analysis identifies BIRC5 as a prognostic biomarker

Original Submission
20 Oct 2021 Submitted Original manuscript
12 Nov 2021 Reviewed Reviewer Report
17 Nov 2021 Reviewed Reviewer Report - Yun Hak Kim
2 Dec 2021 Reviewed Reviewer Report
22 Dec 2021 Author responded Author comments - Anna Fäldt Beding
Resubmission - Version 2
22 Dec 2021 Submitted Manuscript version 2
10 Jan 2022 Author responded Author comments - Anna Fäldt Beding
Resubmission - Version 3
10 Jan 2022 Submitted Manuscript version 3
19 Jan 2022 Author responded Author comments - Anna Fäldt Beding
Resubmission - Version 4
19 Jan 2022 Submitted Manuscript version 4
23 Jan 2022 Author responded Author comments - Anna Fäldt Beding
Resubmission - Version 5
23 Jan 2022 Submitted Manuscript version 5
30 Jan 2022 Reviewed Reviewer Report
30 Jan 2022 Reviewed Reviewer Report
7 Feb 2022 Reviewed Reviewer Report - Yun Hak Kim
26 Feb 2022 Author responded Author comments - Anna Fäldt Beding
Resubmission - Version 6
26 Feb 2022 Submitted Manuscript version 6
2 Mar 2022 Author responded Author comments - Anna Fäldt Beding
Resubmission - Version 7
2 Mar 2022 Submitted Manuscript version 7
3 Mar 2022 Reviewed Reviewer Report - Yun Hak Kim
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
4 Mar 2022 Editorially accepted
25 Mar 2022 Article published 10.1186/s12885-022-09371-0

You can find further information about peer review here.

Back to article page